Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)

SHA:600267 Revenue

Zhejiang Hisun Pharmaceutical had revenue of 2.63B CNY in the quarter ending March 31, 2025, a decrease of -3.48%. This brings the company's revenue in the last twelve months to 9.69B, down -3.43% year-over-year. In the year 2024, Zhejiang Hisun Pharmaceutical had annual revenue of 9.79B, down -5.65%.

• Revenue (ttm): 9.69B
• Revenue Growth: -3.43%
• P/S Ratio: 1.30
• Revenue / Employee: 1.21M
• Employees: 7,994
• Market Cap: 12.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.79B	-586.22M	-5.65%
Dec 31, 2023	10.37B	-1.66B	-13.82%
Dec 31, 2022	12.04B	-99.78M	-0.82%
Dec 31, 2021	12.14B	782.07M	6.89%
Dec 31, 2020	11.35B	282.61M	2.55%